NEW YORK (360Dx) – When a virus or bacteria lies dormant in the body, diagnostic tests to detect pathogens in patient samples will falter. Lophius Biosciences, a Regensburg, Germany-based diagnostics maker, has now developed a technology to interrogate the host immune system in vitro using biomarkers produced when a pathogen antigen is used to stimulate immune cells in a patient's blood sample, indicating a past active infection.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.